The clock is ticking for submitting your concept notes under the second call for project proposals within the Interreg IPA

Rural communities are often the most vulnerable to natural disasters due to limited public services and longer emergency response times.

The March 2025 Edition of our Newsletter is now available, bringing you expert perspectives, key updates, and impactful stories shaping

CROSSCARE enhances cancer diagnosis and treatment in the Romania-Serbia cross-border region, reducing mortality and improving patient outcomes through advanced diagnostics,

After reading the VIM, have you ever wondered about the difference between could and should? Some questions have clear answers,

Mining activities, though essential due to the rising demand for copper, have long-term negative effects on the environment and human

Today, we shine a spotlight on the remarkable women who lead with passion and purpose in our Romanian-Serbian cross-border projects. Their leadership

From March to October, the Otelec border crossing will be open during the last weekend of each month, fostering connections

Exciting news: the ”Victor Babeș” University of Medicine and Pharmacy in Timișoara, in partnership with ”Đorđe Joanović” General Hospital in

This week in Serbia, the training sessions for the beneficiaries of the first call for project proposals under the Interreg

Today, the Monitoring Committee of the Interreg IPA Romania-Serbia Programme approved the extension of the deadline for submitting concept notes

Today, in Timisoara, we organized the first training session for beneficiaries of the 1st call for project proposals under the

With the support of the European Union, the Institute of Cardiovascular Diseases in Timișoara, in partnership with the “Sveti Luka”

Join us at the events dedicated to the promotion of the second call for project proposals of the Interreg IPA Romania-Serbia Programme. Here is

The project partners of the strategic importance project “Harmonizing cardiovascular disease management from prevention to heart transplant in the cross-border area,” RORS00008 financed